Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 Years' followup after the Monroe field trial of VAQTA®

Vaccine

Volumn 20, Issue 13-14, 2002, Pages 1699-1701

  Werzberger, Alan ^a   Mensch, Barbara ^a   Nalin, David R ^b   Kuter, Barbara J ^b  

^a Kiryas Joel Medical Research Institute   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Community; Hepatitis A; Vaccine

Indexed keywords

HEPATITIS A VACCINE; INACTIVATED VACCINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; FOLLOW UP; HEPATITIS A; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; POPULATION EXPOSURE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; UNITED STATES; VACCINATION;

EID: 0037086714     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00042-7     Document Type: Letter

References (8)

1. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children
2. Six years' follow-up after hepatitis A vaccination
3. The role of young children in a community-wide outbreak of hepatitis A
4. ®
5. Hepatitis A virus infection in households
6. Control of hepatitis A through routine vaccination of children